abstract |
This invention relates to a novel class of compounds, diagrammed below, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , D and n are defined therein, which are cysteine protein inhibitors, including, but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone reportion is indicated, such as osteoporosis. |